Reassessment of Urinary Aldosterone Measurement After Saline Infusion in Primary Aldosteronism.

adrenal venous sampling aldosterone primary aldosteronism saline infusion test urinary aldosterone levels

Journal

Journal of the Endocrine Society
ISSN: 2472-1972
Titre abrégé: J Endocr Soc
Pays: United States
ID NLM: 101697997

Informations de publication

Date de publication:
01 Sep 2020
Historique:
received: 14 04 2020
accepted: 20 07 2020
entrez: 18 8 2020
pubmed: 18 8 2020
medline: 18 8 2020
Statut: epublish

Résumé

Urinary aldosterone levels (Uald) are widely measured in the oral sodium-loading test to confirm primary aldosteronism (PA), but reliable studies on their diagnostic value are limited. This may be due to the difficulty in collecting urine with reliable accuracy, keeping oral sodium intake constant between patients. Therefore, we focused on 24-hour Uald after intravenous saline infusion in a hospitalized setting, which provides a reliable sodium load in consistent amounts. Comparing plasma aldosterone concentrations (PAC) and Uald after saline infusion in the sitting position, to evaluate the accuracy in determining PA subtypes and the correlation of both measurements. This was a retrospective cross-sectional study in a single referral center. Of 53 patients without renal dysfunction who were diagnosed with PA and underwent adrenal venous sampling, 16 and 37 were diagnosed with unilateral and bilateral PA, respectively. Uald collected for 24 hours and PAC after saline infusion. The area under the receiver operating characteristic curve for diagnosing unilateral PA was not significantly different between Uald and PAC after saline infusion (0.921 and 0.958, respectively; We reassessed Uald in PA patients under sufficient sodium loading and demonstrated the correlation between Uald and PAC after saline infusion.

Identifiants

pubmed: 32803096
doi: 10.1210/jendso/bvaa100
pii: bvaa100
pmc: PMC7417007
doi:

Types de publication

Journal Article

Langues

eng

Pagination

bvaa100

Informations de copyright

© Endocrine Society 2020.

Références

Clin Endocrinol (Oxf). 2019 May;90(5):641-648
pubmed: 30721529
Ann Endocrinol (Paris). 2016 Jul;77(3):202-7
pubmed: 27318644
Hypertens Res. 2014 Apr;37(4):253-390
pubmed: 24705419
J Clin Endocrinol Metab. 2016 May;101(5):1889-916
pubmed: 26934393
Eur J Endocrinol. 2006 Jun;154(6):865-73
pubmed: 16728547
Horm Metab Res. 2014 Aug;46(9):663-7
pubmed: 24810470
Clin Endocrinol (Oxf). 2007 May;66(5):607-18
pubmed: 17492946
Hypertension. 2013 Jul;62(1):62-9
pubmed: 23648698
Clin Endocrinol (Oxf). 2016 Jun;84(6):814-21
pubmed: 26663435
J Clin Endocrinol Metab. 2004 Mar;89(3):1045-50
pubmed: 15001583
J Clin Endocrinol Metab. 2018 Mar 1;103(3):900-908
pubmed: 29092077
Hypertension. 2013 Aug;62(2):331-6
pubmed: 23753408
Am J Physiol. 1999 Jan;276(1):E43-9
pubmed: 9886949
Mayo Clin Proc. 1990 Jan;65(1):96-110
pubmed: 2404167
J Clin Endocrinol Metab. 2018 Nov 1;103(11):4113-4124
pubmed: 30239841
Endocr J. 2011;58(9):711-21
pubmed: 21828936
Hypertension. 2014 Jan;63(1):151-60
pubmed: 24218436
Am J Med. 1983 Apr;74(4):641-51
pubmed: 6340491
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Clin Endocrinol (Oxf). 2019 Dec;91(6):737-742
pubmed: 31618467
Hypertension. 2018 Mar;71(3):530-537
pubmed: 29358460

Auteurs

Hiroki Kaneko (H)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Hironobu Umakoshi (H)

Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Yuki Ishihara (Y)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Kazutaka Nanba (K)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Mika Tsuiki (M)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Toru Kusakabe (T)

Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Noriko Satoh-Asahara (N)

Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Akihiro Yasoda (A)

Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Tetsuya Tagami (T)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Classifications MeSH